Recovery · Compound

BPC-157

Body Protection Compound 157, a synthetic 15-amino-acid peptide studied for tendon, ligament, muscle and gut injury in rats, with small uncontrolled human reports.

Philippines Peptides editorial deskUpdated 1 October 2026Trial data checked 23 September 20269 min read5 sources

The strongest evidence found for BPC-157 comes from small human studies, and every finding below carries its evidence level.

Availability in the Philippines

Buying BPC-157 in the Philippines

Availability: FDA Philippines: No registered drug product found on the FDA verification portal. US FDA: No record found.
Sourcing channel: Research peptide supplier with stock in Metro Manila

BPC-157 availability in the Philippines

BPC-157 is sold in the Philippines as a research-grade peptide. FDA Philippines: No registered drug product found on the FDA verification portal.

What is BPC-157

BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice (Sikiric 2016 review). It is covered in the peptide library alongside related compounds.

Most BPC-157 research is in rats. In a rat model of Achilles tendon detachment (Krivic 2006), BPC-157 improved measures of tendon healing. In people, the strongest evidence recorded in the evidence dataset is small human studies. Three small uncontrolled human reports only: a 2-person intravenous safety pilot, a 12-patient interstitial cystitis pilot and a 16-patient retrospective knee-pain survey. No completed human randomised trial and no registered trial with results were found.

How it works

BPC-157 is a synthetic 15-amino-acid peptide. A 2025 systematic review summarises animal and cell studies as showing raised growth hormone receptor expression, activation of pathways for cell growth and new blood vessel formation, and lower inflammatory signalling. No receptor has been identified, and the same review notes it is broken down quickly in the liver. None of these mechanisms has been shown in people.

Tendon cells: in a rat tendon cell study (Chang 2011), BPC-157 was associated with tendon outgrowth, cell survival and cell migration.

Gut: a 2016 review (Sikiric et al.) describes protective effects on the gastrointestinal tract in animal models. These are animal findings.

Benefits studied

Interstitial cystitis symptoms
Small human studies
A small uncontrolled pilot in 12 women with interstitial cystitis reported complete symptom resolution in 10, with no placebo or comparison group, so the result cannot separate the peptide from other causes. Source: PubMed 39325560
Knee pain
Small human studies
A retrospective phone survey of 16 clinic patients found 14 reporting knee pain relief; it had no control group and no validated outcome measure. Source: PubMed 34324435
Tendon repair
Animal and cell
In an animal study, rats with a cut Achilles tendon given BPC-157 showed better mechanical, functional and microscopic healing than rats given saline. No human trial has tested this. Source: J Orthop Res 2003
Ligament repair
Animal and cell
In an animal study, rats with a surgically cut knee ligament healed better on functional, mechanical and tissue measures over 90 days with BPC-157. This is animal evidence only. Source: J Orthop Res 2010

Side effects reported

No human trial in the datasets reports adverse-event rates for BPC-157, whose human evidence is limited to small human studies with no completed randomised trial identified. Without controlled data, its safety in people is unknown rather than established.

BPC-157 in the Philippines

A search of the FDA Verification Portal on 23 September 2026 returned no registered drug product for BPC-157. That matters because of the rule every health product sold here sits under: Section 11(a) of RA 3720 as amended by RA 9711 prohibits the manufacture, importation, sale, distribution, promotion or advertising of any health product that is unregistered, adulterated or misbranded. With no registered product, there is nothing for a Philippine pharmacy to dispense, and BPC-157 is sold here as a research-grade vial rather than a finished medicine.

Primara Labs, our partner and supplier, lists BPC-157 as "Lyophilized powder, 20 mg / vial", and it is also one of the components of the store's GLOW Blend and KLOW Blend. The legal research behind this site found no Philippine FDA, DOH, BOC or DDB document that addresses products labelled research use only. The BPC-157 buying guide covers storage and courier handling in Philippine heat.

On enforcement, the legal research behind this site's regulation hub searched FDA Philippines posts for a safety advisory naming BPC-157 and found none. That search covered post text, not attached PDFs.

For research context, the distance between how often BPC-157 is talked about in Manila and what has been measured in people is wide. The evidence dataset counts 0 completed randomised human trials, the human record is limited to small uncontrolled reports, and the tendon and gut findings above come from rats. The most recent synthesis the dataset cites is Vasireddi N et al. HSS J 2025 (systematic review).

Regulatory status

FDA Philippines: No registered drug product found on the FDA verification portal.
US FDA: No record foundDrugs@FDA returned no approved or tentatively approved application for this substance. Drugs@FDA does not list investigational products. Separately, the FDA lists it on its page of bulk drug substances for compounding that may present significant safety risks (current as of 22 April 2026); that page concerns compounding, not approval.
European Medicines Agency: No record foundNo row for this substance in the EMA medicines report generated 22 September 2026. That report does not cover national authorisations in EU member states.
Next milestone: No sponsor identified in any record read.

Checked 23 September 2026. Primary source

How Philippine registration and prescription rules work, and what an unregistered product is under the law, is covered in the regulation hub, and every compound's status side by side is on the status page. This is general information, not legal advice.

Who should not use BPC-157

FAQ

Can you buy BPC-157 at a Philippine pharmacy?

No. A search of the FDA Verification Portal on 23 September 2026 returned no registered drug product for BPC-157. Section 11(a) of RA 3720 as amended by RA 9711 prohibits the manufacture, importation, sale, distribution, promotion or advertising of any health product that is unregistered, adulterated or misbranded. What circulates in the Philippines is the research-grade vial, which is not a medicine. This is general information, not legal advice.

Has FDA Philippines issued a warning about BPC-157?

Not that this site has found. FDA Philippines post searches for advisories naming BPC-157 returned no safety advisory in the legal research behind the regulation hub, checked 23 September 2026. The search covered post text only, not attached PDFs, so a warning inside a PDF would not have been found.

Can BPC-157 be brought into the Philippines from abroad?

BPC-157 has no registered drug product in the Philippines, so the question is one the rules leave open. DOH-FDA-BOC Joint Circular No. 1, dated 22 June 2015, lets travellers bring listed FDA-regulated products into the Philippines without prior FDA clearance if the products are for personal use and within set limits. For prescription drugs, Joint Circular No. 1 sets the allowed quantity as the amount stated on a prescription that carries the physician's PRC licence number or a foreign equivalent. Joint Circular No. 1 does not say whether its prescription-drug allowance covers drugs without a Philippine CPR. No FDA circular that answers this was found. The Bureau of Customs lists pharmaceutical products as regulated imports that require a valid Certificate of Product Registration and/or an FDA License to Operate as importer. This is general information, not legal advice.

What evidence exists for BPC-157?

The strongest human evidence for BPC-157 in the evidence dataset is small human studies, with 0 completed human randomised controlled trials identified. Three small uncontrolled human reports only: a 2-person intravenous safety pilot, a 12-patient interstitial cystitis pilot and a 16-patient retrospective knee-pain survey. No completed human randomised trial and no registered trial with results were found.

What has BPC-157 been studied for?

Tendon, ligament and muscle healing and gastrointestinal injury in rats; interstitial cystitis and knee pain in small uncontrolled human reports. Each finding appears under Benefits studied on this page with its evidence level.

Is BPC-157 registered in the Philippines?

FDA Philippines: No registered drug product found on the FDA verification portal. US FDA: No record found. See the regulatory status page.

Where to get BPC-157 in the Philippines

If the reading is done and the next step is a plan rather than another article, you can build a protocol around your goal at Longevity Manila, which hands off to our partner and supplier, Primara Labs.

The supply index covers what to ask a seller before paying, and why quoted prices vary so widely.

View Supply Index

Primary sources

Citations supporting the clinical claims on this page. Each entry links to the primary record.

All 5 sources: BPC-157 mechanism review: angiogenesis and tendon healing, BPC-157 Achilles tendon outcomes: rat model, BPC-157 corticosteroid-impaired wound healing and more

BPC-157 mechanism review: angiogenesis and tendon healingReview
Sikiric P et al. "Brain-Gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Curr Neuropharmacol 2016;14(8):857-865.
DOI: 10.2174/1570159X13666160502153022
BPC-157 Achilles tendon outcomes: rat modelMechanism
Krivic A et al. "Achilles detachment in rat and stable gastric pentadecapeptide BPC 157." J Orthop Res 2006;24(5):982-989.
DOI: 10.1002/jor.20096
BPC-157 corticosteroid-impaired wound healingMechanism
Tkalcevic VI et al. "Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression." Eur J Pharmacol 2007;570(1-3):212-221.
DOI: 10.1016/j.ejphar.2007.05.072
BPC-157 muscle injury and growth hormone receptor expressionMechanism
Chang CH et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol 2011;110(3):774-780.
DOI: 10.1152/japplphysiol.00945.2010
FDA bulk drug substance review: 503A compoundingLabel
US FDA. "Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act." Decision: BPC-157 not on the 503A allowed list.
Source

Risk · Disclosure · Editorial Status

This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician (ideally one with peptide-specific clinical experience) before starting any compound, adjusting a dose, or discontinuing therapy.

In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.

Editorial Status: Non-clinical
Affiliation: Not a clinic · Not a pharmacy
Last Updated: October 1, 2026